Welcome to our dedicated page for Colgate Palmolive Co SEC filings (Ticker: CL), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Colgate-Palmolive Company (NYSE: CL) SEC filings page on Stock Titan brings together the company’s regulatory disclosures, including Forms 10-K, 10-Q, 8-K and other documents filed with the U.S. Securities and Exchange Commission. These filings provide detailed information on Colgate-Palmolive’s Oral Care, Personal Care, Home Care and Pet Nutrition businesses, its financial performance and its capital structure.
Colgate-Palmolive’s 8-K filings illustrate how the company uses SEC reports to communicate material events. For example, an 8-K dated November 10, 2025 describes the execution of an underwriting agreement and the issuance of €600,000,000 of 3.250% Senior Notes due 2035 under an automatic shelf registration statement. Other 8-Ks furnish quarterly earnings press releases and explain multi-year productivity initiatives, such as the Strategic Growth and Productivity Program designed to support the company’s 2030 strategy by aligning its organizational structure, optimizing its global supply chain and streamlining overhead.
Filings also list Colgate-Palmolive’s securities registered under Section 12(b) of the Exchange Act, including its common stock (ticker CL) and various series of notes traded on the New York Stock Exchange. Through proxy statements and other periodic reports, investors can review topics such as segment reporting, non-GAAP financial measures like Base Business and organic sales growth, and risk factor disclosures.
On Stock Titan, these SEC documents are updated from EDGAR and paired with AI-powered summaries that highlight key points, such as changes in capital allocation, new debt offerings, productivity program charges or revisions to guidance. Users can quickly scan filings for material information while retaining access to the complete original documents for deeper analysis.
Insider share withholding for tax on vested RSUs — The Form 4 shows John Hazlin, listed as Chief Growth Officer and officer of Colgate-Palmolive Co (CL), reported share dispositions on 09/12/2025 and 09/13/2025. The filings record withholding of 377 and 449 shares respectively at an implied price of $83.28 per share to satisfy tax liabilities from the vesting of restricted stock units.
After these withholdings Hazlin beneficially owns 17,629 shares directly and 5,382 shares indirectly through the issuer's 401(k) plan trustee. The Form 4 was signed by an attorney-in-fact and includes the standard explanation that the transactions were share withholdings for tax payment.
Malcolm Gregory, listed as Executive Vice President and Controller of Colgate-Palmolive Company (CL), reported routine share withholding to cover tax liabilities from vesting restricted stock units. The form shows two small dispositions: 89 shares disposed on 09/12/2025 and 152 shares disposed on 09/13/2025, each at a price of $83.28. After the 09/12 transaction he beneficially owned 12,057 shares directly and after 09/13 he beneficially owned 11,905 shares directly. He also holds 8,445 shares indirectly through the issuer's 401(k) plan trustee. The filing explains these dispositions were the withholding of shares to pay tax on vested restricted stock units. The form is signed on behalf of the reporting person by an attorney-in-fact.
Sally Massey, Chief Human Resources Officer of Colgate-Palmolive Company, reported the withholding and disposal of shares to cover taxes on vested restricted stock units. The filing shows two non-derivative transactions: 447 shares disposed on 09/12/2025 at $83.28 and 669 shares disposed on 09/13/2025 at $83.28, a total of 1,116 shares sold to satisfy tax withholding. After these transactions she beneficially owned 14,946 shares directly, and additionally held 8,004 shares indirectly through the issuer's 401(k) plan trustee. The form was signed by an attorney-in-fact on 09/16/2025. The filer explained the disposals were withholdings for tax liability incident to RSU vesting.
Parameswaran Prabha, Vice Chair of Colgate-Palmolive Co (CL), reported two small sales of common stock on 09/12/2025 and 09/13/2025. The Form 4 shows withholding of 699 shares on 09/12/2025 and 979 shares on 09/13/2025, both priced at $83.28 per share, reported as dispositions. After those transactions the reporting person’s direct beneficial ownership is listed as 11,018 shares. The filing also discloses 5,955 shares held indirectly via the issuer’s 401(k) plan trustee and 46,810 shares held indirectly by a trust. The filing states the share disposals were withholdings to satisfy tax liabilities on vested restricted stock units and is signed by an attorney-in-fact on 09/16/2025.
Stanley J. Sutula III, Chief Financial Officer of Colgate-Palmolive (CL), reported dispositions of company stock tied to restricted stock unit tax withholding. On 09/12/2025 he disposed of 784 shares at $83.28 and on 09/13/2025 he disposed of 1,352 shares at $83.28. After those transactions his beneficial ownership is reported as 55,596 shares held directly and 324 shares held indirectly through the issuer's 401(k) plan trustee. The form indicates the share disposals were for withholding to satisfy tax liabilities on vested restricted stock units. The filing was signed by an attorney-in-fact on 09/16/2025.
Tsourapas Panagiotis, an officer (COO, Eur., APac, Afr Eur, Skin) of Colgate-Palmolive Company (CL), reported routine withholding of shares to cover taxes on vested restricted stock units. On 09/12/2025, 521 shares were withheld at $83.28 and on 09/13/2025, 900 shares were withheld at $83.28. Following these transactions the reporting person directly beneficially owned 11,475 shares and indirectly owned 4,509 shares through the issuer's 401(k) plan trustee and 60,745 shares via a trust. The filing was signed by an attorney-in-fact on 09/16/2025.
Colgate-Palmolive insider transaction summary: Director and Chairman, President & CEO Noel R. Wallace reported withholding-related disposals of company common stock tied to restricted stock unit vesting. On 09/12/2025, 2,972 shares were disposed at $83.28 per share; on 09/13/2025, 4,777 shares were disposed at $83.28. These disposals reduced Mr. Wallace's direct beneficial ownership from 344,492 shares to 339,715 shares following the reported transactions.
Mr. Wallace also holds indirect positions: 53,560 shares via the issuer's 401(k) plan trustee, 52,000 shares via a spouse trust, and 335 shares via another trust. The filer explains the transactions were withholding of shares to satisfy tax liabilities on vested restricted stock units.
Colgate-Palmolive's Chairman, President & CEO received equity awards on 09/11/2025 consisting of 28,314 restricted stock units and a stock option for 196,047 shares with an exercise price of $84.06. The restricted stock units vest in three equal annual installments starting one year after grant, and the option vests in equal annual installments over three years beginning one year after the grant, with an expiration in 2033. Following the transaction the reporting person directly beneficially owns 347,464 shares, and holds additional indirect holdings of 53,560 shares via the issuer's 401(k) trustee, 52,000 shares via a spouse trust, and 335 shares via another trust. The awards were reported on a Form 4 reflecting standard compensation plan grants to an executive director.
Tsourapas Panagiotis, Colgate-Palmolive Company COO (Eur., APac, Afr Eur, Skin) reported equity awards on 09/11/2025. The filing shows a grant of 4,759 restricted stock units that vest in three equal annual installments beginning on the first anniversary of the grant. The report also discloses 32,949 stock options with an exercise price of $84.06; the options vest in equal annual installments over three years beginning on 09/11/2026 and expire on 09/11/2033. Following the transactions, the reporting person directly beneficially owns 11,996 shares and beneficially owns additional shares indirectly: 4,509 via the issuer's 401(k) plan trustee and 60,745 via trust (which includes 10,774 previously reported as direct). The form was signed 09/12/2025.
Colgate-Palmolive's chief financial officer received equity awards from the company as disclosed on a Section 16 filing. The filing shows a grant of 8,328 restricted stock units and a stock option for 57,661 underlying shares with an exercise price of $84.06 and an expiration in 2033. After the reported transactions the reporting person beneficially owned 57,732 shares directly and held 324 shares indirectly through the issuer's 401(k) plan trustee. The restricted stock units vest in three equal annual installments and the option vests in equal annual installments over three years.